Driven, goal-oriented leader seeking to bridge the gap between the research lab and the clinic through personal effort and investment in commercialization of high impact discoveries. Dedicated to the development of regenerative therapies to extend cognitive lifespan and treat neurodegenerative diseases such as ALS. Current directions include the preclinical development of microglial replacement to enable the introduction of transgenic cells into the brain and spinal cord. Broader longevity interests include the development of tools for high resolution biomarkers to allow rapid testing of aging interventions, and determining the contribution of various organs and systems to aging of the CNS.My background in neuroscience, biochemistry, biosensor development, molecular biology, semiconductor engineering, angel investing, and entrepreneurship offers unique perspectives on challenging problems.